← Back to Search

Behavioral Intervention

Enhanced Conversational Recast for Childhood Language Disorders

N/A
Recruiting
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Hearing loss
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-3 days per week over 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will enroll children aged 4 to 6 years who have trouble developing language skills but do not have any other major health issues. The children will undergo tests to confirm a diagnosis of developmental language

Who is the study for?
This trial is for children aged 4-6 who struggle with language development and have been diagnosed with a developmental language disorder. They should not have other conditions that could affect learning. Participants will be tested to confirm their diagnosis before joining.
What is being tested?
The study tests the 'Enhanced Conversational Recast' treatment, which aims to improve language skills in children with language disorders. It involves a six-week half-day summer camp program followed by an assessment six weeks later to measure retained learning.
What are the potential side effects?
Since this trial focuses on educational intervention rather than medication, traditional side effects are not applicable. However, there may be varying responses to the therapy based on individual child's engagement and learning ability.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have hearing loss.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-3 days per week over 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-3 days per week over 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in the use of grammatical forms in untreated contexts
Change in the use of treated grammatical forms in untreated contexts
Retention of trained grammatical forms
+1 more
Secondary study objectives
Spontaneous use of trained grammatical forms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Grammar treatment including semantic supportExperimental Treatment1 Intervention
Children receiving grammatical treatment will also receive a simple explanation concerning the meaning of verbs used to elicit grammatical forms.
Group II: Grammatical treatment excluding semantic supportActive Control1 Intervention
Children receiving grammatical treatment will not receive any explanation concerning the meaning of verbs used to elicit grammatical forms.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
534 Previous Clinical Trials
159,451 Total Patients Enrolled
~15 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top